This trial will test a new device to see if it is safe and effective at treating blocked arteries.
- Peripheral Artery Disease
- Peripheral Arterial Disease
1 Primary · 4 Secondary · Reporting Duration: 30 Days
1 Treatment Group
AngioSafe Peripheral CTO Crossing System Procedure
1 of 1
100 Total Participants · 1 Treatment Group
Primary Treatment: AngioSafe Peripheral CTO Crossing System · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 9 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is there availability to join this experiment?
"That is correct. According to the data on clinicaltrials.gov, this research study has been actively searching for patients since February 1st 2021 and most recently modified on November 22nd 2022. As of now, 100 individuals are needed from 18 locations." - Anonymous Online Contributor
To what extent is the current research involving individuals receiving treatment?
"Affirmative. Clinicaltrials.gov confirms that this clinical investigation, which was first published on February 1st 2021, is actively recruiting patients for enrolment. The project requires 100 individuals to be enrolled at 18 different research sites." - Anonymous Online Contributor
Can you enumerate the sites where this medical trial is being conducted?
"This clinical trial is being administered through Dignity Health - Chandler Regional Medical Center in Arizona, Vascular Care Group in Massachusetts, and Coastal Vascular & Interventional, PLLC in Florida. Additionally there are 18 other sites hosting this research project." - Anonymous Online Contributor